Amid the sultry summer months, a few signs of fall become apparent, such as the appearance of school supplies on stores ...

Most Americans get the vaccine in the form of a shot. FluMist is the only spray-in-the-nose vaccine on the market. It was first licensed in 2003 and is approved for healthy people ages 2 to 49.

The US Food and Drug Administration is reviewing an application for the nasal spray flu vaccine FluMist to be able to be self-administered at home, drugmaker AstraZeneca said Tuesday.

FluMist is the first vaccine to prevent influenza, more commonly known as the flu, that does not need to be administered by a ...

FluMist’s return to the U.S. market occurred shortly before the arrival of the Covid-19 pandemic, which has led to an overall decline in the use of flu vaccine.

FluMist, the only non-injected flu vaccine licensed in the United States, has regained a place on the list of flu vaccines that the Centers for Disease Control recommends for use, ending what was ...

FluMist Vaccine Lost Its Punch : Shots - Health News A CDC advisory panel concluded the nasal spray vaccine is so ineffective that it shouldn't be used by anyone during the 2016-2017 flu season.

The FDA has approved the at-home use of FluMist, a nasal spray flu vaccine, available in fall 2025. Effective for healthy people aged 2 to 49, it offers a needle-free option but isn't suitable for ...

A nurse prepares an injection of the influenza vaccine at Massachusetts General Hospital in Boston, Mass. in this January 10, 2013 file photo. BRIAN SNYDER / Reuters June 26, 2016, 6:33 AM EDT ...

FluMist, the needle-free nasal spray vaccine pulled from the U.S. market in 2016, may return after vaccine advisers recommended a reformulated version.

In June, the CDC said the popular nasal flu vaccine isn't effective based on its use in U.S. children. But a new Canadian study says that it does indeed work. It's not at all clear who's right.